Pacific Biosciences Of California PE Ratio 2010-2024 | PACB
Current and historical p/e ratio for Pacific Biosciences Of California (PACB) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pacific Biosciences Of California PE ratio as of September 13, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pacific Biosciences Of California PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-09-13 | 1.81 | 0.00 | |
| 2024-06-30 | 1.37 | $-1.50 | 0.00 |
| 2024-03-31 | 3.75 | $-1.14 | 0.00 |
| 2023-12-31 | 9.81 | $-1.21 | 0.00 |
| 2023-09-30 | 8.35 | $-1.27 | 0.00 |
| 2023-06-30 | 13.30 | $-1.35 | 0.00 |
| 2023-03-31 | 11.58 | $-1.39 | 0.00 |
| 2022-12-31 | 8.18 | $-1.40 | 0.00 |
| 2022-09-30 | 5.81 | $-1.34 | 0.00 |
| 2022-06-30 | 4.42 | $-0.92 | 0.00 |
| 2022-03-31 | 9.10 | $-0.81 | 0.00 |
| 2021-12-31 | 20.46 | $-0.89 | 0.00 |
| 2021-09-30 | 25.55 | $-0.21 | 0.00 |
| 2021-06-30 | 34.97 | $-0.43 | 0.00 |
| 2021-03-31 | 33.31 | $-0.37 | 0.00 |
| 2020-12-31 | 25.94 | $0.09 | 288.22 |
| 2020-09-30 | 9.87 | $-0.28 | 0.00 |
| 2020-06-30 | 3.45 | $-0.33 | 0.00 |
| 2020-03-31 | 3.06 | $-0.34 | 0.00 |
| 2019-12-31 | 5.14 | $-0.55 | 0.00 |
| 2019-09-30 | 5.16 | $-0.76 | 0.00 |
| 2019-06-30 | 6.05 | $-0.76 | 0.00 |
| 2019-03-31 | 7.23 | $-0.77 | 0.00 |
| 2018-12-31 | 7.40 | $-0.77 | 0.00 |
| 2018-09-30 | 5.41 | $-0.74 | 0.00 |
| 2018-06-30 | 3.55 | $-0.74 | 0.00 |
| 2018-03-31 | 2.05 | $-0.83 | 0.00 |
| 2017-12-31 | 2.64 | $-0.89 | 0.00 |
| 2017-09-30 | 5.25 | $-0.92 | 0.00 |
| 2017-06-30 | 3.56 | $-0.92 | 0.00 |
| 2017-03-31 | 5.17 | $-0.87 | 0.00 |
| 2016-12-31 | 3.80 | $-0.84 | 0.00 |
| 2016-09-30 | 8.96 | $-0.65 | 0.00 |
| 2016-06-30 | 7.04 | $-0.44 | 0.00 |
| 2016-03-31 | 8.50 | $-0.50 | 0.00 |
| 2015-12-31 | 13.13 | $-0.53 | 0.00 |
| 2015-09-30 | 3.66 | $-0.64 | 0.00 |
| 2015-03-31 | 5.84 | $-0.93 | 0.00 |
| 2014-12-31 | 7.84 | $-0.94 | 0.00 |
| 2014-09-30 | 4.91 | $-0.94 | 0.00 |
| 2014-06-30 | 6.18 | $-0.97 | 0.00 |
| 2014-03-31 | 5.35 | $-1.01 | 0.00 |
| 2013-12-31 | 5.23 | $-1.06 | 0.00 |
| 2015-06-30 | 5.76 | $-1.17 | 0.00 |
| 2013-09-30 | 5.52 | $-1.40 | 0.00 |
| 2013-06-30 | 2.53 | $-1.50 | 0.00 |
| 2013-03-31 | 2.49 | $-1.57 | 0.00 |
| 2012-12-31 | 1.70 | $-1.70 | 0.00 |
| 2012-09-30 | 1.83 | $-1.73 | 0.00 |
| 2012-06-30 | 2.17 | $-1.86 | 0.00 |
| 2012-03-31 | 3.42 | $-1.88 | 0.00 |
| 2011-12-31 | 2.80 | $-2.04 | 0.00 |
| 2011-09-30 | 3.21 | $-2.59 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.491B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.606B | 28.12 |
| Intuitive Surgical (ISRG) | United States | $175.549B | 99.40 |
| Alcon (ALC) | Switzerland | $49.699B | 34.99 |
| IQVIA Holdings (IQV) | United States | $43.460B | 24.63 |
| Edwards Lifesciences (EW) | United States | $41.042B | 26.31 |
| IDEXX Laboratories (IDXX) | United States | $40.909B | 49.21 |
| DexCom (DXCM) | United States | $27.578B | 39.33 |
| STERIS (STE) | Ireland | $24.307B | 28.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.261B | 0.00 |
| Waters (WAT) | United States | $19.119B | 28.50 |
| Hologic (HOLX) | United States | $18.679B | 20.31 |
| Sysmex ADR (SSMXY) | Japan | $12.455B | 39.06 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.842B | 13.28 |
| Teleflex (TFX) | United States | $11.437B | 17.78 |
| Globus Medical (GMED) | United States | $9.487B | 26.54 |
| Penumbra (PEN) | United States | $7.769B | 80.65 |
| Glaukos (GKOS) | United States | $6.939B | 0.00 |
| Masimo (MASI) | United States | $6.011B | 32.19 |
| TransMedics (TMDX) | United States | $4.975B | 213.06 |
| Integer Holdings (ITGR) | United States | $4.231B | 24.74 |
| PROCEPT BioRobotics (PRCT) | United States | $4.175B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.865B | 0.00 |
| Inari Medical (NARI) | United States | $2.677B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.646B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.462B | 15.32 |
| Elekta AB (EKTAY) | Sweden | $2.393B | 19.50 |
| Veracyte (VCYT) | United States | $2.337B | 144.86 |
| RxSight (RXST) | United States | $2.017B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.369B | 6.24 |
| Pulse Biosciences (PLSE) | United States | $1.159B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.108B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.082B | 19.30 |
| OPKO Health (OPK) | United States | $1.081B | 0.00 |
| Artivion (AORT) | United States | $1.037B | 95.19 |
| Alphatec Holdings (ATEC) | United States | $0.770B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.765B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.658B | 16.61 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.649B | 0.00 |
| SiBone (SIBN) | United States | $0.640B | 0.00 |
| Paragon 28 (FNA) | United States | $0.613B | 0.00 |
| IRadimed (IRMD) | United States | $0.607B | 32.79 |
| AxoGen (AXGN) | United States | $0.595B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.336B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.335B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.315B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.315B | 9.59 |
| AngioDynamics (ANGO) | United States | $0.302B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.267B | 0.00 |
| NeuroPace (NPCE) | United States | $0.211B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.172B | 12.05 |
| Alpha Tau Medical (DRTS) | Israel | $0.167B | 0.00 |
| CVRx (CVRX) | United States | $0.166B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.135B | 0.00 |
| 908 Devices (MASS) | United States | $0.120B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.119B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.096B | 14.27 |
| WORK Medical Technology Group (WOK) | China | $0.075B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Envoy Medical (COCH) | United States | $0.066B | 0.00 |
| LENSAR (LNSR) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.029B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Spectral AI (MDAI) | United States | $0.023B | 0.00 |
| Neuronetics (STIM) | United States | $0.022B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |